主动脉瓣或二尖瓣外科置换术后感染性心内膜炎:一项全国性人群研究
该研究基于台湾全民健康保险研究数据库,纳入2000至2017年接受主动脉瓣或二尖瓣置换术的患者22844例,按机械瓣或生物瓣分组并进行倾向性评分匹配。匹配后每组5441例,生物瓣组感染性心内膜炎风险显著高于机械瓣组(3.4% vs 1.9%;亚分布风险比1.78;95%CI 1.40-2.26),但机械瓣组缺血性卒中和出血并发症风险更高。
要点
- 生物瓣组感染性心内膜炎风险显著高于机械瓣组(3.4% vs 1.9%;亚分布风险比1.78;95%CI 1.40-2.26)。
- 生物瓣与全因死亡和再次瓣膜手术风险较高相关,但与缺血性卒中、出血性卒中、大出血和胃肠道出血风险较低相关。
- 亚组分析中生物瓣与感染性心内膜炎风险较高的一致性关联见于所有亚组。
核心结论
- 在这项全国性人群回顾性队列研究中,生物瓣使用与随访期间感染性心内膜炎风险高于机械瓣使用相关,但机械瓣使用与缺血性卒中和出血并发症风险较高相关。
研究设计与样本
- 全国性人群回顾性队列研究,从台湾全民健康保险研究数据库识别2000至2017年接受主动脉瓣或二尖瓣置换术的患者,按机械瓣或生物瓣分组,并进行倾向性评分匹配以减少混杂。
主要发现
- 共纳入22844例患者,机械瓣组11950例(52.2%),生物瓣组10934例(47.8%);匹配后每组5441例。
- 随访期间生物瓣组感染性心内膜炎风险显著高于机械瓣组(3.4% vs 1.9%;亚分布风险比1.78;95%CI 1.40-2.26)。
- 生物瓣与全因死亡和再次瓣膜手术风险较高相关,但与缺血性卒中、出血性卒中、大出血和胃肠道出血风险较低相关。
- 亚组分析中,生物瓣与感染性心内膜炎风险较高的一致性关联见于所有亚组,具体包括单瓣置换-主动脉瓣、单瓣置换-二尖瓣、双瓣置换、活动性感染性心内膜炎(指数住院期间诊断的感染性心内膜炎)、任何感染性心内膜炎(活动性或陈旧性)以及无感染性心内膜炎病史。
关键数值与推荐
- 生物瓣组感染性心内膜炎发生率3.4%,机械瓣组1.9%,亚分布风险比1.78(95%CI 1.40-2.26)。
- 匹配后每组各5441例。
- 共纳入22844例,机械瓣组11950例(52.2%),生物瓣组10934例(47.8%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Evidence regarding the incidence of prosthetic valve endocarditis and its association with the use of mechanical or biologic prosthetic valves is limited. METHODS: Patients who underwent aortic or mitral valve replacement in the years 2000 to 2017 were identified from Taiwan's National Health Insurance Research Database and grouped according to the type of prosthesis used (mechanical or biologic). Propensity score matching was performed to reduce confounding. RESULTS: A total of 22,844 patients were included, with 11,950 (52.2%) and 10,934 (47.8%) in the mechanical prosthesis and biologic prosthesis groups, respectively. After matching, each group contained 5441 patients. During follow-up, patients with a biologic prosthesis had a significantly higher risk of infective endocarditis (IE) than those with a mechanical valve (3.4% vs 1.9%; subdistribution hazard ratio, 1.78; 95% CI, 1.40-2.26). Moreover, biologic prostheses were associated with greater risks of all-cause mortality and redo valve surgery, but lesser risks of ischemic stroke, hemorrhagic stroke, major bleeding, and gastrointestinal bleeding. In subgroup analysis, biologic prostheses were consistently associated with a greater risk of IE in all subgroups, specifically single-valve replacement-aortic, single-valve replacement-mitral, double-valve replacement, active IE (IE diagnosed during index hospitalization), any IE (active or old), and not having a history of IE. CONCLUSIONS: In this nationwide population-based retrospective cohort study, biologic prosthesis use was associated with a greater risk of IE during follow-up compared with mechanical valve use. However, mechanical valve use was associated with a greater risk of ischemic stroke and hemorrhagic complications.
引用
- Lee HA, Wu VC, Chan YS, et al. Infective endocarditis after surgical aortic or mitral valve replacement: A nationwide population-based study. J Thorac Cardiovasc Surg. 2021. PMID: 35086668. doi:10.1016/j.jtcvs.2021.12.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。